• 1
    Trey C. The fulminant hepatic failure surveillance study: brief review of the effects of presumed etiology and age of survival. Can Med Assoc J 1992; 106 (suppl): 522527
  • 2
    Douglas DD, Rekela J. Fulminant hepatitis. In: KaplowitzN, ed. Liver and biliary diseases. Ed 1. Baltimore: Williams & Wilkins, 1992: 279288.
  • 3
    Higgins GM, Anderson RM. Restoration of the liver of the white rat following partial surgical removal. AMA Arch Pathol 1931; 12: 186202.
  • 4
    Rozga J, Jeppsson B, Bengmark S. Portal branch ligation in the rat: reeval-uation of a model. Am J Pathol 1986; 125: 300308.
  • 5
    Lowry OH, Rosebough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265275.
  • 6
    Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y, Nakamura T. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissue. Biochem Res 1995; 16: 105114.
  • 7
    Lidofsky S. Liver transplantation for fulminant hepatic failure. Gastroen-terol Clin North Am 1993; 22: 257269.
  • 8
    Terblanche J, Hickman R. Animal model of fulminant hepatic failure. Dig Dis Sci 1991; 6: 1522.
  • 9
    Mullen KD, Schafer DF, Maynard TF, DeKnegt R, Jones DB, Roessle M, Jones EA. Galactosamine induced fulminant hepatic failure in the rat may be an unsuitable model for acute hepatic encephalopathy; a comparison with the rabbit model [Abstract]. Gastroenterology 1986; 90: 1750.
  • 10
    Tabata Y, Chang TMS. Comparisons of six artificial liver support regimens in fulminant hepatic failure rats. Trans Am Soc Artif Intern Organs 1980; 26: 394399.
  • 11
    Emond J, Capron-Laudereau M, Meriggi F, Bernuau J, Reynes M, Houssin D. Extent of hepatectomy in the rat. Eur Surg Res 1989; 21: 251259.
  • 12
    Demetriou AA, Reisner A, Sanchez A, Levenson SM, Moscioni AD, Chowd-hury JR. Transplantation of microcarrier-attached hepatocytes into 90% partial hepatectomized rats. Hepatology 1988; 8: 10061009.
  • 13
    Gaub J, Iversen J. Rat liver regeneration after 90% partial hepatectomy. Hepatology 1984; 4: 902904.
  • 14
    Zieve L, Anderson WR, Lindblad S. Course of hepatic regeneration after 80% to 90% resection of normal rat liver. J Lab Clin Med 1985; 105: 331336.
  • 15
    Weinbren K, Tarsh E. The mitotic response in the rat liver after different regenerative stimuli. Br J Exp Pathol 1964; 45: 475480.
  • 16
    Rozga J, Jeppsson B, Hagerstand I, Bengmark S. Acute portal vein stenosis. An experimental study on portal circulation and hepatosplenic function. Acta Chir Scand 1985; 151: 125131.
  • 17
    Mappes G. Experimentelle erzeugung einer portalen hypertension bei der ratte. Arch Klin Chir 1960; 295: 795800.
  • 18
    Danzi F, Pozos RS. Accidental hypothermia. New Engl J Med 1996; 331: 17561760.
  • 19
    Traber P, DalCanto M, Ganger D, Blei AT. Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devasculariza-tion. Gastroenterology 1989; 96: 885891.
  • 20
    Peignoux M, Bernuau J, Benhamou JP. Total hepatectomy and hepatic vascular exclusion in the rat. A comparison with special reference to the influence of body temperature. Clin Sci 1982; 62: 273277.
  • 21
    Schenker S, Warren KS. Effect of temparature variation on toxicity and metabolism of ammonia in mice. J Lab Clin Med 1960; 60: 291296.
  • 22
    Zieve L, Doizaki WM, Lyftogt C. Brain methanethiol and ammonia concentrations in experimental hepatic coma and coma induced by injection of combination of these substances. J Lab Clin Med 1984; 104: 665674.
  • 23
    Chen S, Watanabe FD, Wang C-C, Eguchi S, Demetriou AA, Rozga J. Presence of liver necrosis is needed for development of intracranial hypertension in acute liver failure [Abstract]. Hepatology 1995; 22: 381A.
  • 24
    Rozga J, Podesta L, LePage E, Hoffman A, Morsiani E, Sher L, Woolf GM, et al. Control of cerebral edema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993; 342: 898899.
  • 25
    Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, Miyazaki H, et al. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 1989; 9: 875881.
  • 26
    Higuchi O, Nakamura T. Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis. Biochem Biophys Res Commun 1991; 176: 599607.
  • 27
    Sakon M, Monden M, Gotoh M, et al. Hepatocyte growth factor concentrations after liver resection. Lancet 1992; 339: 818.
  • 28
    Matsumoto K, Tajima H, Okazaki H, Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-b̃1 and glucocorticoids. J Biol Chem 1992; 267: 2491724920.
  • 29
    Gomez-Lechon MJ, Castelli J, Guillen I, O'Connor E, Nakamura T, Fabra R, Trullenque R. Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture. Hepatology 1995; 21: 12481254.
  • 30
    Braun L, Mead JE, Panzica M, Mikuno R, Bell GI. Transforming growth factor b̃ mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 1988; 85: 15391543.
  • 31
    Russell WE, Coffey RJ, Ouellette AJ, Moses HL. Type b̃ transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 1988; 85: 51265130.
  • 32
    Armendariz-Borunda J, Katai H, Jones MC, Seyer JM, Kang AH, Raghow R. Transforming growth factor b̃ gene expression is transiently enhanced at a critical stage during liver regeneration after CCl4 treatment. Lab Invest 1993; 69: 283294.